Boston Scientific Corporation
No price chart data available for 1D timeframe.
Rating
Why Price Moved
Shares are trading lower after Boston Scientific c...
Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
Boston Scientific Corporation (BSX) operates as a global leader in medical technology, specializing in the design, manufacturing, and commercialization of innovative medical devices tailored for a div...
Latest News
2 days ago · zacks.com
Intuitive Surgical vs. Boston Scientific: Which Stock Is a Better Buy Now?Intuitive Surgical's surging robotic surgery demand and stronger earnings momentum make it a better buy than Boston Scientific despite its valuation premium.
3 days ago · zacks.com
New Strong Sell Stocks for October 30thBSX, NBHC and NMRK have been added to the Zacks Rank #5 (Strong Sell) List on October 30th, 2026.
4 days ago · zacks.com
BSX Q3 Earnings Call Flags Growth Challenges Through 2027Boston Scientific faces a challenging 2027 as cybersecurity disruptions, EP and WATCHMAN weakness and China pricing pressures weigh on growth prospects.
4 days ago · benzinga.com
These Analysts Revise Their Forecasts On Boston Scientific After Q3 ResultsBoston Scientific Corp (NYSE:BSX) on Wednesday posted upbeat third-quarter financial results and cut its FY26 guidance below estimates.
4 days ago · marketbeat.com
Boston Scientific Q3 Earnings Call HighlightsBoston Scientific NYSE: BSX reported third-quarter 2026 results that fell below its prior guidance after a cybersecurity incident disrupted manufacturing and product shipments for eight business days, while competitive and pricing pressures weighed on key cardiovascular franchises.
4 days ago · fool.com
Boston Scientific: 3 Key Takeaways for Long-Term InvestorsAn eight-day cyber outage reduced third-quarter sales by $150 million. Management expects full-year 2026 organic revenue growth of 4%.
4 days ago · fool.com
Stock Market Today, Oct. 28: Boston Scientific Slips 6% After Cutting Q4 Sales and Full-Year EPS Guidance on Cyberattack ImpactNYSE · As of 4:00 PM ET 10/28/26
5 days ago · zacks.com
BSX Q3 Earnings Meet Estimates, Revenues Rise Y/Y, Stock DownBoston Scientific's third-quarter revenues beat estimates, but contracting margins, weaker segment sales and reduced 2026 guidance weigh on shares.
5 days ago · seekingalpha.com
Boston Scientific Corporation (BSX) Q3 2026 Earnings Call TranscriptBoston Scientific Corporation (BSX) Q3 2026 Earnings Call Transcript
5 days ago · zacks.com
Compared to Estimates, Boston Scientific (BSX) Q3 Earnings: A Look at Key MetricsThe headline numbers for Boston Scientific (BSX) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Earnings
Analyst Summary
Add to Watchlist
Select watchlists to add or remove BSX